Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 175

1.

Bisphenol A, Chlorinated Derivatives of Bisphenol A and Occurrence of Myocardial Infarction in Patients with Type 2 Diabetes: Nested Case-Control Studies in Two European Cohorts.

Hu C, Schöttker B, Venisse N, Limousi F, Saulnier PJ, Albouy-Llaty M, Dupuis A, Brenner H, Migeot V, Hadjadj S.

Environ Sci Technol. 2019 Jul 31. doi: 10.1021/acs.est.9b02963. [Epub ahead of print]

PMID:
31310111
2.

The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study.

Oshima M, Jun M, Ohkuma T, Toyama T, Wada T, Cooper ME, Hadjadj S, Hamet P, Harrap S, Mancia G, Marre M, Williams B, Chalmers J, Woodward M, Perkovic V; ADVANCE Collaborative Group.

Diabetologia. 2019 Jul 13. doi: 10.1007/s00125-019-4948-4. [Epub ahead of print]

PMID:
31302707
3.

Metformin overdose: A serious iatrogenic complication-Western France Poison Control Centre Data Analysis.

Stevens A, Hamel JF, Toure A, Hadjadj S, Boels D.

Basic Clin Pharmacol Toxicol. 2019 Jun 19. doi: 10.1111/bcpt.13273. [Epub ahead of print]

PMID:
31215744
4.

No association between fear of hypoglycemia and blood glucose variability in type 1 diabetes: The cross-sectional VARDIA study.

Saulnier PJ, Briet C, Gand E, Chaillous L, Dubois S, Bonnet F, Leguerrier AM, Fradet G, Delcourt Crespin I, Kerlan V, Gouet D, Perlemoine C, Ducluzeau PH, Pichelin M, Wargny M, Gonder-Frederick L, Ragot S, Hadjadj S, Cariou B; VARDIA study group.

J Diabetes Complications. 2019 Aug;33(8):554-560. doi: 10.1016/j.jdiacomp.2019.05.003. Epub 2019 May 10.

PMID:
31182337
5.

Lower limb events in individuals with type 2 diabetes: evidence for an increased risk associated with diuretic use.

Potier L, Roussel R, Velho G, Saulnier PJ, Bumbu A, Matar O, Schneider F, Ragot S, Marre M, Mohammedi K, Hadjadj S.

Diabetologia. 2019 Jun;62(6):939-947. doi: 10.1007/s00125-019-4835-z. Epub 2019 Feb 26.

PMID:
30809716
6.

Interest of albuminuria in nephrology, diabetology and as a marker of cardiovascular risk.

Souweine JS, Corbel A, Rigothier C, Roque CD, Hadjadj S, Cristol JP, Combe C, Bigot-Corbel E, Beauvieux MC; groupe de travail SFBC, SFNDT, SNP.

Ann Biol Clin (Paris). 2019 Feb 1;77(1):26-35. doi: 10.1684/abc.2018.1402. Review.

PMID:
30799295
7.

Prospective evaluation of a dynamic insulin infusion algorithm for non critically-ill diabetic patients: A before-after study.

Montanier N, Bernard L, Lambert C, Pereira B, Desbiez F, Terral D, Abergel A, Bohatier J, Rosset E, Schmidt J, Sautou V, Hadjadj S, Batisse-Lignier M, Tauveron I, Maqdasy S, Roche B.

PLoS One. 2019 Jan 28;14(1):e0211425. doi: 10.1371/journal.pone.0211425. eCollection 2019.

8.

Efficacy and adherence of glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes mellitus in real-life settings.

Guerci B, Charbonnel B, Gourdy P, Hadjadj S, Hanaire H, Marre M, Vergès B.

Diabetes Metab. 2019 Jan 21. pii: S1262-3636(19)30021-7. doi: 10.1016/j.diabet.2019.01.006. [Epub ahead of print] Review.

PMID:
30677504
9.

Baroreflex sensitivity assessed with the sequence method is associated with ventricular arrhythmias in patients implanted with a defibrillator for the primary prevention of sudden cardiac death.

Garcia R, Degand B, Fraty M, Le Marcis V, Bidegain N, Laude D, Tavernier M, Le Gal F, Hadjadj S, Saulnier PJ, Ragot S.

Arch Cardiovasc Dis. 2019 Apr;112(4):270-277. doi: 10.1016/j.acvd.2018.11.009. Epub 2019 Jan 19.

PMID:
30670362
10.

A novel rare CUBN variant and three additional genes identified in Europeans with and without diabetes: results from an exome-wide association study of albuminuria.

Ahluwalia TS, Schulz CA, Waage J, Skaaby T, Sandholm N, van Zuydam N, Charmet R, Bork-Jensen J, Almgren P, Thuesen BH, Bedin M, Brandslund I, Christensen CK, Linneberg A, Ahlqvist E, Groop PH, Hadjadj S, Tregouet DA, Jørgensen ME, Grarup N, Pedersen O, Simons M, Groop L, Orho-Melander M, McCarthy MI, Melander O, Rossing P, Kilpeläinen TO, Hansen T.

Diabetologia. 2019 Feb;62(2):292-305. doi: 10.1007/s00125-018-4783-z. Epub 2018 Dec 13.

11.

Multiethnic Genome-Wide Association Study of Diabetic Retinopathy Using Liability Threshold Modeling of Duration of Diabetes and Glycemic Control.

Pollack S, Igo RP Jr, Jensen RA, Christiansen M, Li X, Cheng CY, Ng MCY, Smith AV, Rossin EJ, Segrè AV, Davoudi S, Tan GS, Chen YI, Kuo JZ, Dimitrov LM, Stanwyck LK, Meng W, Hosseini SM, Imamura M, Nousome D, Kim J, Hai Y, Jia Y, Ahn J, Leong A, Shah K, Park KH, Guo X, Ipp E, Taylor KD, Adler SG, Sedor JR, Freedman BI; Family Investigation of Nephropathy and Diabetes-Eye Research Group, DCCT/EDIC Research Group, Lee IT, Sheu WH, Kubo M, Takahashi A, Hadjadj S, Marre M, Tregouet DA, Mckean-Cowdin R, Varma R, McCarthy MI, Groop L, Ahlqvist E, Lyssenko V, Agardh E, Morris A, Doney ASF, Colhoun HM, Toppila I, Sandholm N, Groop PH, Maeda S, Hanis CL, Penman A, Chen CJ, Hancock H, Mitchell P, Craig JE, Chew EY, Paterson AD, Grassi MA, Palmer C, Bowden DW, Yaspan BL, Siscovick D, Cotch MF, Wang JJ, Burdon KP, Wong TY, Klein BEK, Klein R, Rotter JI, Iyengar SK, Price AL, Sobrin L.

Diabetes. 2019 Feb;68(2):441-456. doi: 10.2337/db18-0567. Epub 2018 Nov 28.

12.

Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy.

Skupien J, Smiles AM, Valo E, Ahluwalia TS, Gyorgy B, Sandholm N, Croall S, Lajer M, McDonnell K, Forsblom C, Harjutsalo V, Marre M, Galecki AT, Tregouet DA, Wu CY, Mychaleckyj JC, Nickerson H, Pragnell M, Rich SS, Pezzolesi MG, Hadjadj S, Rossing P, Groop PH, Krolewski AS.

Diabetes Care. 2019 Jan;42(1):93-101. doi: 10.2337/dc18-1369. Epub 2018 Nov 19.

PMID:
30455333
13.

Prognostic value of plasma MR-proADM vs NT-proBNP for heart failure in people with type 2 diabetes: the SURDIAGENE prospective study.

Fraty M, Velho G, Gand E, Fumeron F, Ragot S, Sosner P, Mohammedi K, Gellen B, Saulnier PJ, Halimi JM, Montaigne D, Ducrocq G, Rehman M, Marre M, Roussel R, Hadjadj S; SURDIAGENE Study Group.

Diabetologia. 2018 Dec;61(12):2643-2653. doi: 10.1007/s00125-018-4727-7. Epub 2018 Sep 19.

PMID:
30232509
14.

Prognostic Values of Inflammatory and Redox Status Biomarkers on the Risk of Major Lower-Extremity Artery Disease in Individuals With Type 2 Diabetes.

Nativel M, Schneider F, Saulnier PJ, Gand E, Ragot S, Meilhac O, Rondeau P, Burillo E, Cournot M, Potier L, Velho G, Marre M, Roussel R, Rigalleau V, Mohammedi K, Hadjadj S.

Diabetes Care. 2018 Oct;41(10):2162-2169. doi: 10.2337/dc18-0695. Epub 2018 Aug 2.

PMID:
30072406
15.

Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes.

Velho G, Ragot S, El Boustany R, Saulnier PJ, Fraty M, Mohammedi K, Fumeron F, Potier L, Marre M, Hadjadj S, Roussel R.

Cardiovasc Diabetol. 2018 Aug 2;17(1):110. doi: 10.1186/s12933-018-0753-5.

16.

Glycosuria amount in response to hyperglycaemia and risk for diabetic kidney disease and related events in Type 1 diabetic patients.

Carpentier C, Dubois S, Mohammedi K, Belhatem N, Bouhanick B, Rohmer V, Briet C, Bumbu A, Hadjadj S, Roussel R, Potier L, Velho G, Marre M.

Nephrol Dial Transplant. 2018 Jul 5. doi: 10.1093/ndt/gfy197. [Epub ahead of print]

PMID:
29982607
17.

Long-term negative impact of an inappropriate first antiepileptic medication on the efficacy of a second antiepileptic medication in mice.

Pawluski JL, Kuchenbuch M, Hadjadj S, Dieuset G, Costet N, Vercueil L, Biraben A, Martin B.

Epilepsia. 2018 Jul;59(7):e109-e113. doi: 10.1111/epi.14454. Epub 2018 Jun 14.

18.

Influence of micro- and macro-vascular disease and Tumor Necrosis Factor Receptor 1 on the level of lower-extremity amputation in patients with type 2 diabetes.

Schneider F, Saulnier PJ, Gand E, Desvergnes M, Lefort N, Thorin E, Thorin-Trescases N, Mohammedi K, Ragot S, Ricco JB, Hadjadj S.

Cardiovasc Diabetol. 2018 Jun 8;17(1):81. doi: 10.1186/s12933-018-0725-9.

19.

A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.

van Zuydam NR, Ahlqvist E, Sandholm N, Deshmukh H, Rayner NW, Abdalla M, Ladenvall C, Ziemek D, Fauman E, Robertson NR, McKeigue PM, Valo E, Forsblom C, Harjutsalo V; Finnish Diabetic Nephropathy Study (FinnDiane), Perna A, Rurali E, Marcovecchio ML, Igo RP Jr, Salem RM, Perico N, Lajer M, Käräjämäki A, Imamura M, Kubo M, Takahashi A, Sim X, Liu J, van Dam RM, Jiang G, Tam CHT, Luk AOY, Lee HM, Lim CKP, Szeto CC, So WY, Chan JCN; Hong Kong Diabetes Registry Theme-based Research Scheme Project Group, Ang SF, Dorajoo R, Wang L, Clara TSH, McKnight AJ, Duffy S; Warren 3 and Genetics of Kidneys in Diabetes (GoKinD) Study Group, Pezzolesi MG; GENIE (GEnetics of Nephropathy an International Effort) Consortium, Marre M, Gyorgy B, Hadjadj S, Hiraki LT; Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group, Ahluwalia TS, Almgren P, Schulz CA, Orho-Melander M, Linneberg A, Christensen C, Witte DR, Grarup N, Brandslund I, Melander O, Paterson AD, Tregouet D, Maxwell AP, Lim SC, Ma RCW, Tai ES, Maeda S, Lyssenko V, Tuomi T, Krolewski AS, Rich SS, Hirschhorn JN, Florez JC, Dunger D, Pedersen O, Hansen T, Rossing P, Remuzzi G; SUrrogate markers for Micro- and Macrovascular hard endpoints for Innovative diabetes Tools (SUMMIT) Consortium, Brosnan MJ, Palmer CNA, Groop PH, Colhoun HM, Groop LC, McCarthy MI.

Diabetes. 2018 Jul;67(7):1414-1427. doi: 10.2337/db17-0914. Epub 2018 Apr 27.

20.

Novel risk genes identified in a genome-wide association study for coronary artery disease in patients with type 1 diabetes.

Charmet R, Duffy S, Keshavarzi S, Gyorgy B, Marre M, Rossing P, McKnight AJ, Maxwell AP, Ahluwalia TVS, Paterson AD, Trégouët DA, Hadjadj S.

Cardiovasc Diabetol. 2018 Apr 25;17(1):61. doi: 10.1186/s12933-018-0705-0.

21.

Sex Difference In the Effect of Fetal Exposure to Maternal Diabetes on Insulin Secretion.

Gautier JF, Fetita LS, Riveline JP, Ibrahim F, Porcher R, Abi Khalil C, Velho G, Choukem SP, Hadjadj S, Larger E, Roussel R, Boudou P, Marre M, Ravussin E, Mauvais-Jarvis F.

J Endocr Soc. 2018 Mar 22;2(5):391-397. doi: 10.1210/js.2017-00482. eCollection 2018 May 1.

22.

No prognostic role of a GWAS-derived genetic risk score in renal outcomes for patients from French cohorts with type 1 and type 2 diabetes.

Barbieux P, György B, Gand E, Saulnier PJ, Ducrocq G, Halimi JM, Feigerlova E, Hulin-Delmotte C, Llaty P, Montaigne D, Rigalleau V, Roussel R, Sosner P, Zaoui P, Ragot S, Marre M, Tregouët DA, Hadjadj S; SURDIAGENE Study Group; French JDRF Diabetic Nephropathy Collaborative Research Initiative (Search for genes determining time to onset of ESRD in T1D patients with proteinuria).

Diabetes Metab. 2018 Feb 10. pii: S1262-3636(18)30038-7. doi: 10.1016/j.diabet.2018.01.016. [Epub ahead of print] No abstract available.

PMID:
29540294
23.

Circulating Concentrations of Redox Biomarkers Do Not Improve the Prediction of Adverse Cardiovascular Events in Patients With Type 2 Diabetes Mellitus.

Cournot M, Burillo E, Saulnier PJ, Planesse C, Gand E, Rehman M, Ragot S, Rondeau P, Catan A, Gonthier MP, Feigerlova E, Meilhac O, Hadjadj S.

J Am Heart Assoc. 2018 Feb 25;7(5). pii: e007397. doi: 10.1161/JAHA.117.007397.

24.

Plasma levels of hsa-miR-152-3p are associated with diabetic nephropathy in patients with type 2 diabetes.

Roux M, Perret C, Feigerlova E, Mohand Oumoussa B, Saulnier PJ, Proust C, Trégouët DA, Hadjadj S.

Nephrol Dial Transplant. 2018 Dec 1;33(12):2201-2207. doi: 10.1093/ndt/gfx367.

PMID:
29361146
25.

Plasma proprotein-convertase-subtilisin/kexin type 9 (PCSK9) and cardiovascular events in type 2 diabetes.

El Khoury P, Roussel R, Fumeron F, Abou-Khalil Y, Velho G, Mohammedi K, Jacob MP, Steg PG, Potier L, Ghaleb Y, Elbitar S, Ragot S, Andreata F, Caligiuri G, Hadjadj S, Boileau C, Marre M, Abifadel M, Varret M, Hansel B.

Diabetes Obes Metab. 2018 Apr;20(4):943-953. doi: 10.1111/dom.13181. Epub 2018 Jan 14.

PMID:
29205760
26.

Plasma concentrations of 8-hydroxy-2'-deoxyguanosine and risk of kidney disease and death in individuals with type 1 diabetes.

Sanchez M, Roussel R, Hadjadj S, Moutairou A, Marre M, Velho G, Mohammedi K.

Diabetologia. 2018 Apr;61(4):977-984. doi: 10.1007/s00125-017-4510-1. Epub 2017 Nov 28.

PMID:
29185011
27.

White blood cell fractions correlate with lesions of diabetic kidney disease and predict loss of kidney function in Type 2 diabetes.

Wheelock KM, Saulnier PJ, Tanamas SK, Vijayakumar P, Weil EJ, Looker HC, Hanson RL, Lemley KV, Yee B, Knowler WC, Hadjadj S, Najafian B, Mauer M, Nelson RG.

Nephrol Dial Transplant. 2017 Dec 1;32(12):2145. doi: 10.1093/ndt/gfx303. No abstract available.

PMID:
29088394
28.

T-cadherin gene variants are associated with nephropathy in subjects with type 1 diabetes.

Nicolas A, Mohammedi K, Bastard JP, Fellahi S, Bellili-Muñoz N, Roussel R, Hadjadj S, Marre M, Velho G, Fumeron F.

Nephrol Dial Transplant. 2017 Dec 1;32(12):2144. doi: 10.1093/ndt/gfx290. No abstract available.

PMID:
29048523
29.

White blood cell fractions correlate with lesions of diabetic kidney disease and predict loss of kidney function in Type 2 diabetes.

Wheelock KM, Saulnier PJ, Tanamas SK, Vijayakumar P, Weil EJ, Looker HC, Hanson RL, Lemley KV, Yee B, Knowler WC, Hadjadj S, Najafian B, Mauer M, Nelson RG.

Nephrol Dial Transplant. 2018 Jun 1;33(6):1001-1009. doi: 10.1093/ndt/gfx231.

PMID:
28992267
30.

IL-33 receptor ST2 deficiency attenuates renal ischaemia-reperfusion injury in euglycaemic, but not streptozotocin-induced hyperglycaemic mice.

Sehnine M, Ferhat M, Sena S, Gombert JM, Goujon JM, Thierry A, Touchard G, Hauet T, Herbelin A, Hadjadj S.

Diabetes Metab. 2018 Feb;44(1):55-60. doi: 10.1016/j.diabet.2017.06.008. Epub 2017 Sep 12.

31.

Association of impaired renal function with venous thrombosis: A genetic risk score approach.

Charmet R, van Hylckama Vlieg A, Germain M, Roussel R, Marre M, Debette S, Amouyel P, Deleuze JF, Hadjadj S, Rosendaal FR, Morange PE, Trégouët DA.

Thromb Res. 2017 Oct;158:102-107. doi: 10.1016/j.thromres.2017.08.015. Epub 2017 Aug 25.

PMID:
28866378
32.

Urinary lysophopholipids are increased in diabetic patients with nephropathy.

Saulnier-Blache JS, Feigerlova E, Halimi JM, Gourdy P, Roussel R, Guerci B, Dupuy A, Bertrand-Michel J, Bascands JL, Hadjadj S, Schanstra JP.

J Diabetes Complications. 2017 Jul;31(7):1103-1108. doi: 10.1016/j.jdiacomp.2017.04.024. Epub 2017 May 10.

PMID:
28506691
33.

T-cadherin gene variants are associated with nephropathy in subjects with type 1 diabetes.

Nicolas A, Mohammedi K, Bastard JP, Fellahi S, Bellili-Muñoz N, Roussel R, Hadjadj S, Marre M, Velho G, Fumeron F.

Nephrol Dial Transplant. 2017 Dec 1;32(12):1987-1993. doi: 10.1093/ndt/gfx071.

PMID:
28499019
34.

Retinal microvascular alterations related to diabetes assessed by optical coherence tomography angiography: A cross-sectional analysis.

Gozlan J, Ingrand P, Lichtwitz O, Cazet-Supervielle A, Benoudis L, Boissonnot M, Hadjadj S, Leveziel N.

Medicine (Baltimore). 2017 Apr;96(15):e6427. doi: 10.1097/MD.0000000000006427.

35.

A parental history of diabetes is associated with a high risk of retinopathy in patients with type 2 diabetes.

Lapeyre G, Cougnard-Grégoire A, Delyfer MN, Delcourt C, Hadjadj S, Blanco L, Pupier E, Rougier MB, Rajaobelina K, Mohammedi K, Hugo M, Korobelnik JF, Rigalleau V.

Diabetes Metab. 2017 Dec;43(6):557-559. doi: 10.1016/j.diabet.2017.02.006. Epub 2017 Mar 30. No abstract available.

PMID:
28365211
36.

Urinary Sodium Concentration Is an Independent Predictor of All-Cause and Cardiovascular Mortality in a Type 2 Diabetes Cohort Population.

Saulnier PJ, Gand E, Ragot S, Bankir L, Piguel X, Fumeron F, Rigalleau V, Halimi JM, Marechaud R, Roussel R, Hadjadj S; SURDIAGENE Study group.

J Diabetes Res. 2017;2017:5327352. doi: 10.1155/2017/5327352. Epub 2017 Feb 1.

37.

Association of Circulating Biomarkers (Adrenomedullin, TNFR1, and NT-proBNP) With Renal Function Decline in Patients With Type 2 Diabetes: A French Prospective Cohort.

Saulnier PJ, Gand E, Velho G, Mohammedi K, Zaoui P, Fraty M, Halimi JM, Roussel R, Ragot S, Hadjadj S; SURDIAGENE Study Group.

Diabetes Care. 2017 Mar;40(3):367-374. doi: 10.2337/dc16-1571. Epub 2016 Dec 20.

PMID:
27998909
38.

Glycaemic control influences the relationship between plasma PCSK9 and LDL cholesterol in type 1 diabetes.

Laugier-Robiolle S, Vergès B, Le Bras M, Gand E, Bouillet B, Saulnier PJ, Le May C, Pichelin M, Maréchaud R, Petit JM, Hadjadj S, Cariou B.

Diabetes Obes Metab. 2017 Mar;19(3):448-451. doi: 10.1111/dom.12819. Epub 2016 Dec 8.

PMID:
27804190
39.

Plasma Copeptin, Kidney Outcomes, Ischemic Heart Disease, and All-Cause Mortality in People With Long-standing Type 1 Diabetes.

Velho G, El Boustany R, Lefèvre G, Mohammedi K, Fumeron F, Potier L, Bankir L, Bouby N, Hadjadj S, Marre M, Roussel R.

Diabetes Care. 2016 Dec;39(12):2288-2295. Epub 2016 Oct 11.

PMID:
27729425
40.

The Genetic Landscape of Renal Complications in Type 1 Diabetes.

Sandholm N, Van Zuydam N, Ahlqvist E, Juliusdottir T, Deshmukh HA, Rayner NW, Di Camillo B, Forsblom C, Fadista J, Ziemek D, Salem RM, Hiraki LT, Pezzolesi M, Trégouët D, Dahlström E, Valo E, Oskolkov N, Ladenvall C, Marcovecchio ML, Cooper J, Sambo F, Malovini A, Manfrini M, McKnight AJ, Lajer M, Harjutsalo V, Gordin D, Parkkonen M; The FinnDiane Study Group, Tuomilehto J, Lyssenko V, McKeigue PM, Rich SS, Brosnan MJ, Fauman E, Bellazzi R, Rossing P, Hadjadj S, Krolewski A, Paterson AD; The DCCT/EDIC Study Group, Florez JC, Hirschhorn JN, Maxwell AP; GENIE Consortium, Dunger D, Cobelli C, Colhoun HM, Groop L, McCarthy MI, Groop PH; SUMMIT Consortium.

J Am Soc Nephrol. 2017 Feb;28(2):557-574. doi: 10.1681/ASN.2016020231. Epub 2016 Sep 19.

41.

Initial Combination of Empagliflozin and Metformin in Patients With Type 2 Diabetes.

Hadjadj S, Rosenstock J, Meinicke T, Woerle HJ, Broedl UC.

Diabetes Care. 2016 Oct;39(10):1718-28. doi: 10.2337/dc16-0522. Epub 2016 Aug 4.

PMID:
27493136
42.

ANGPTL2 is associated with an increased risk of cardiovascular events and death in diabetic patients.

Gellen B, Thorin-Trescases N, Sosner P, Gand E, Saulnier PJ, Ragot S, Fraty M, Laugier S, Ducrocq G, Montaigne D, Llaty P, Rigalleau V, Zaoui P, Halimi JM, Roussel R, Thorin E, Hadjadj S.

Diabetologia. 2016 Nov;59(11):2321-2330. doi: 10.1007/s00125-016-4066-5. Epub 2016 Aug 4.

PMID:
27491833
43.

Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion.

Zannad F, Stough WG, Lipicky RJ, Tamargo J, Bakris GL, Borer JS, Alonso García Mde L, Hadjadj S, Koenig W, Kupfer S, McCullough PA, Mosenzon O, Pocock S, Scheen AJ, Sourij H, Van der Schueren B, Stahre C, White WB, Calvo G.

Eur Heart J Cardiovasc Pharmacother. 2016 Jul;2(3):200-5. doi: 10.1093/ehjcvp/pvw007. Epub 2016 Apr 3. Review.

44.

Sex hormone levels are not associated with progression of renal disease in male patients with T2DM.

Feigerlová E, Saulnier PJ, Gourdy P, Roussel R, Halimi JM, Gand E, Dardari D, Guerci B, Sosner P, Marre M, Zaoui P, Ragot S, Hadjadj S; DIAB 2 NEPHROGENE, SURDIAGENE Study Groups.

Diabetes Metab. 2017 Apr;43(2):140-145. doi: 10.1016/j.diabet.2016.05.012. Epub 2016 Jun 22.

PMID:
27344412
45.

Dynamic Changes in Renal Function Are Associated With Major Cardiovascular Events in Patients With Type 2 Diabetes.

Ragot S, Saulnier PJ, Velho G, Gand E, de Hauteclocque A, Slaoui Y, Potier L, Sosner P, Halimi JM, Zaoui P, Rigalleau V, Fumeron F, Roussel R, Marre M, Hadjadj S; SURDIAGENE and DIABHYCAR study groups.

Diabetes Care. 2016 Jul;39(7):1259-66. doi: 10.2337/dc15-2607. Epub 2016 May 23.

PMID:
27222502
46.

Predictors of High Motivation Score for Performing Research Initiation Fellowship, Master 1, Research Master 2, and PhD Curricula During Medical Studies: A Strobe-Compliant Article.

Feigerlova E, Oussalah A, Fournier JP, Antonelli A, Hadjadj S, Marechaud R, Guéant JL, Roblot P, Braun M.

Medicine (Baltimore). 2016 Feb;95(5):e2633. doi: 10.1097/MD.0000000000002633.

47.

Glutathione peroxidase-1 gene (GPX1) variants, oxidative stress and risk of kidney complications in people with type 1 diabetes.

Mohammedi K, Patente TA, Bellili-Muñoz N, Driss F, Le Nagard H, Fumeron F, Roussel R, Hadjadj S, Corrêa-Giannella ML, Marre M, Velho G.

Metabolism. 2016 Feb;65(2):12-9. doi: 10.1016/j.metabol.2015.10.004. Epub 2015 Oct 28.

PMID:
26773925
48.

Lower-extremity amputation as a marker for renal and cardiovascular events and mortality in patients with long standing type 1 diabetes.

Mohammedi K, Potier L, Belhatem N, Matallah N, Hadjadj S, Roussel R, Marre M, Velho G.

Cardiovasc Diabetol. 2016 Jan 7;15:5. doi: 10.1186/s12933-015-0322-0.

49.

Electrical atrial vulnerability and renal complications in type 2 diabetes.

Montaigne D, Coisne A, Sosner P, Lacroix D, Hadjadj S.

Diabetologia. 2016 Apr;59(4):861-2. doi: 10.1007/s00125-015-3840-0. Epub 2015 Dec 24. No abstract available.

PMID:
26704624
50.

Modeling the synergistic antibacterial effects of honey characteristics of different botanical origins from the Sahara Desert of Algeria.

Laallam H, Boughediri L, Bissati S, Menasria T, Mouzaoui MS, Hadjadj S, Hammoudi R, Chenchouni H.

Front Microbiol. 2015 Nov 6;6:1239. doi: 10.3389/fmicb.2015.01239. eCollection 2015.

Supplemental Content

Loading ...
Support Center